Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Clarcon Biological Chemistry Laboratory Inc.
483
•Clarcon Biological Chemistry Laboratory Inc.•May 4, 2009

Clarcon Biological Chemistry Laboratory Inc. – FDA 483, May 4, 2009

Record Details

The FDA Form 483 inspection revealed numerous deficiencies at the facility. A primary concern is the absence of a quality control unit (QCU), with Dr. Bonada claiming sole responsibility for both QCU functions and manufacturing, and no written QCU responsibilities.

Significant manufacturing process control issues were identified, including the lack of validation for drug manufacturing processes, equipment cleaning, purified water manufacturing, and laboratory methods. Master production and control records are not prepared, dated, or signed, and no written procedures exist for their preparation. Batch production and control records are incomplete, missing critical information such as component identification, in-process and laboratory control results, packaging area inspections, yield statements, labeling control records, container descriptions, sampling details, personnel identification, investigation records, and examination results.

Finished product testing is deficient, as the firm does not test for the identity and strength of the active ingredient, benzalkonium chloride, prior to release. Employee training in current good manufacturing practices (cGMP) is undocumented. The facility lacks written procedures for production and process controls, and for the receipt, identification, storage, handling, sampling, testing, approval, and rejection of components, drug product containers, and closures.

Equipment and containers are improperly identified, with various unidentified containers of finished product found in production and storage areas. There is no written stability testing program, and no stability data to support expiration dating. Active ingredient samples are not retained. Equipment maintenance, cleaning, sanitizing, and inspection

Company
Clarcon Biological Chemistry Laboratory Inc.
Inspection date
May 4, 2009
Product type
Drugs
Office
Denver District Office
Person
  • Matthew R. Dionne (Compliance Officer)
View Company Profile

ID · e9549e34-690a-423c-a46c-0d1043f37db3

Violation Codes2
21 CFR 211.19221 CFR 211.134

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Clarcon Biological Chemistry Laboratory Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.